Your pharmacy does not have your medicine in stock. That is frustrating, but it does not yet tell you whether a national shortage exists. Useful information must match the exact product, strength and presentation. A notice about a similar medicine does not automatically answer your question.

Identify the exact medicine first

Have the full product name, prescribed strength and presentation ready. A national pack identifier, if available, helps the pharmacy identify the right item. The active ingredient alone is insufficient: different brands or forms may have different authorised uses and instructions.

Ask whether the pack is simply absent from that pharmacy, unavailable from its usual wholesaler or affected by a reported supply disruption. Agree how and when you will receive another update. An estimated delivery date remains an estimate until the pharmacy can confirm the pack is available.

What a shortage list can tell you

Official lists may give the start date, affected packs or expected duration of a reported problem. They do not show the shelves of every pharmacy in real time. Resumed supply does not mean packs have already arrived everywhere. Equally, an individual pharmacy may still have stock during a wider disruption.

Check when the information was updated and read the explanation of its scope. Countries do not all monitor exactly the same medicines or supply events. Consequently, the absence of an entry is not a reliable promise that your next prescription can be dispensed immediately.

Official information in six countries

In Germany, the BfArM provides information about medicine shortages. In Austria, the BASG service Medikamente Info Austria links to reported supply restrictions. Switzerland publishes information through the Federal Office for National Economic Supply and its medicines reporting office; its defined coverage matters.

In France, ANSM publishes medicine availability information. In Italy, AIFA maintains the carenti list and explains how national shortages differ from local distribution problems. In Spain, AEMPS provides reported supply problems through CIMA. The linked official sources are a better starting point than an old social media post.

Plan a possible interruption together

Contact your pharmacy and prescriber as soon as a gap in supply becomes foreseeable. Explain when your next scheduled use is due and how much medicine you actually have left. The treatment team needs to decide whether and how the plan should change, considering why you take the medicine and your other treatments.

Do not stretch intervals, divide pens or exchange active ingredients yourself. Restarting after an interruption may also require a fresh clinical decision. If you have already missed a scheduled use, consult the current leaflet for your exact product and your treatment team. A general internet rule cannot safely cover every medicine.

Do not let scarcity pressure decide the purchase

A claim that a medicine is scarce does not prove that an offered pack is genuine. Private chats and social media offers may seem especially attractive while you are waiting. Use verifiable, legally permitted supply routes. Marketing authorisation does not automatically permit cross-border online delivery.

Agree with the pharmacy how it can reach you and whether it can reserve a pack. Avoid buying beyond the needs agreed in your treatment plan. A short written note with the next contact date and responsible practice makes the follow-up clearer and saves repeating the same uncertain conversation.

Common questions

Does an unavailable pack mean I have to change medicine?

No. A missing pack in one pharmacy does not determine the medical decision. First establish the actual supply situation. Your treatment team must assess whether an alternative is appropriate and legally available. Similar names or matching ingredients are not enough to justify changing the treatment yourself.

Can this page tell me where a pack is available today?

No. This article explains where to obtain information and has no access to live pharmacy stock. Ask a licensed pharmacy about a particular pack. Regulatory notices provide additional context but cannot replace a current dispensing enquiry.

Sources & further reading

  1. BfArM: Lieferengpässe
  2. BASG: Medikamente Info Austria
  3. BWL: Meldestelle Heilmittel
  4. ANSM: Disponibilités des médicaments
  5. AIFA: Farmaci carenti
  6. AEMPS: Problemas de suministro
  7. EMA: Illegal medicines warning

Sources checked:

eu. infopoint editorial team

Researched and created with AI assistance. This article has not undergone individual review by a medical professional.

About our health information

Published:

Report a correction

Questions and experiences

Share a question or a useful experience about this topic. Every contribution is checked before publication. Comments may be written in different languages.

Loading reader contributions…

Opening the form sets a necessary session cookie. No email address is required. Publication is subject to moderation and is not guaranteed. For deletion requests: Contact